胃癌组织α-连接蛋白与幽门螺杆菌感染的相关性研究

摘要/Abstract

摘要： 目的探讨胃癌发生过程中α-连接蛋白(alpha-catenin,α-Cat)表达与幽门螺杆菌(helicobacter pylori,Hp)感染的关系,及其在胃癌发生发展中的可能机制。方法选择胃黏膜活检及手术切除的胃癌病理标本96例,癌旁组织96例,对照标本15例。应用免疫组化SP法检测各组组织中α-Cat的表达。用快速尿素酶试验或组织学Warthin-Starry嗜银染色法检测胃黏膜Hp感染情况。结果α-Cat在胃癌组、癌旁组织组、对照组的阳性表达率分别为34.4%、56.2%、100.0%,胃癌组显著低于癌旁组织组和对照组(P<0.05);96例胃癌组织中Hp阳性组α-Cat表达明显低于Hp阴性组(46.3%vs59.2%,P<0.05);α-Cat阳性率在高、中分化和低、未分化型胃癌组织中阳性率呈现递减趋势(69.1%vs10.7%,P<0.01),但α-Cat表达和淋巴结转移、癌肿浸润深度无密切相关。结论在胃黏膜癌变过程中,α-Cat的表达逐渐上调。胃癌组织中α-Cat的表达与Hp感染相关,提示Hp感染可通过对α-Cat表达的影响,在胃癌的发生发展过程中发挥一定作用。

关键词: 幽门螺杆菌, 胃癌, α-连接蛋白(alpha-catenin)

Abstract: Objective To investigate the expression and the clinical significance of Alpha-Catenin(α-Cat) in carcinogenesis of gastric mucosa and its relationship with Helicobacter pylori(Hp) infection.Methods SP immunohistochemical technique was used to detect the expression of α-Cat in 96 cases of gastric carcinoma tissue and their adjacent tissues,and 15 control tissues.Rapid urease test and histological staining Warthin-Starry were used to determine the status of Hp infection.Results The positive rates of α-Cat expression in gastric cancer tissues,cancer-adjacent tissues and control tissues were 34.4%,56.2% and 100% respective1y(P<0.05).The expression of α-Cat in the Hp-positive cancer tissues was markedly lower than that in Hp-negative ones(36.2% vs.51.8%,P<0.05).The positive rate of α-Cat in cancer tissue was positively paralleled with the increase of differentiation grade,but there was no significant difference between the positive rate of α-Cat and the depth of tumor invasion or lymph node metastasis(P>0.05).Conclusions The expression of α-Cat was gradually down-regulated during the course of gastric carcinogenesis.Hp infection is closely related to the expression of α-Cat in gastric cancer.Hp infection might be an initiating factor,and the activation of α-Cat might be one of the key events in the pathogenesis of gastric cancer.Hp infection and α-Cat expression play synergic roles in occurrence and development of gastric cancer.

Key words: Helicobacter pylori, Gastric cancer

黄振宁;覃山羽;姜海行;胡榜利;. 胃癌组织α-连接蛋白与幽门螺杆菌感染的相关性研究[J]. 中国癌症防治杂志, 2009, 1(03): 214-217.

HUANG Zhen-ning,QIN Shan-yu,JIANG Hai-xing,et al.. The relationship of Helicobacter pylori infection and the expression of alpha-catenin in gastric cancer[J]. Chinese Journal of Oncology Prevention and Treatment, 2009, 1(03): 214-217.

参考文献

1Lundin BS,Enarsson K,Kindlund B,et al.The local and systemic T-cell response to Helicobacter pylori in gastric cancer patients is characterised by production of interleukin-10[J].Clinical Immunology,2007,125(2):205-213. 2Ohkuma K,Okada M,Murayama H,et al.Association of Helicobacter pylori infec-tion with atrophic gastritis and intestinal metaplasia[J].Journal of Gastroenterol-ogy and Hepatology,2000,15(10):1105-12. 3Lee SA,Kang D,Shim KN,et al.Effect of diet and Helicobacter pylori infection to the risk of early gastric cancer[J].Journal of Epidemiology,2003,13(3):162-168. 4丁小云,李定国,陆汉明,等.幽门螺杆菌感染的胃黏膜上皮细胞环氧合酶-2表达及意义[J].中华肿瘤杂志,2005,(27):232-234. 5PolatA,Cinel L,Dusmez D,etal.Expression of cell-cycle related proteins in Heli-cobacter pylori gastritis and association with gastric carcinoma[J].Neoplasma,2002,49(2):95-100. 6Kodama M,Fujioka T,Murakami K,et al.Eradication of Helicobacter pylori re-duced the immunohistochemical detection of p53and MDM2in gastric mucosa[J].Journal of Gastroenterology and Hepatology,2005,20(6):941-946. 7Suzuki M,Mimuro H,Suzuki T,etal.Interaction of CagAwith Crk plays an impor-tant role in Helicobacter pylori-induced loss of gastric epithelial cell adhesion[J].The Journal of Experimental Medicine,2005,202(9):1235-47. 8Kuniyasu H,Kitadai Y,Mieno H,et al.Helicobactor pylori infection is closely as-sociated with telomere reduction in gastric mucosa[J].Oncology,2003,65(3):275-282. 9Lan J,Xiong YY,Lin YX,et al.Helicobacter pylori infection generated gastric cancer through p53-Rb tumor-suppressor system mutation and telomerase reactiva-tion[J].World Journal of Gastroenterology,2003,9(1):54-58. 10Yao M,Kargman S,LamEC,etal.Inhibition of cyclooxygenase-2by rofecoxib at-tenuates the growth and metastatic potential of colorectal carcinoma in mice[J].Cancer Research,2003,63(3):586-592. 11Forman D.The prevalence of Helicobacter pylori infection in gastric cancer[J].Alimentary Pharmacology&Therapeutics,1995,9Suppl2:71-76. 12Sasaki T,Shimura H,Akama Y,et al.Discrepancy between E-cadherin protein expression and morphology in human gastric carcinoma cells[J].Hepatogastro-enterology,2005,52(66):1920-24. 13Shapiro L,Fannon AM,Kwong PD,et al.Structural basis of cell-cell adhesion by cadherins[J].Nature,1995,374(6520):327-337. 14Zhou YN,Xu CP,Chen Y,et al.Alpha-catenin expression is decreased in pa-tients with gastric carcinoma[J].World Journal of Gastroenterology2005,11(22):3468-72. 15Joo YE,RewJS,Kim HS,et al.Changes in the E-cadherin-catenin complex ex-pression in early and advanced gastric cancers[J].Digestion,2001,64(2):111-119. 16Shun CT,Wu MS,Lin MT,etal.Immunohistochemical evaluation of cadherin and catenin expression in early gastric carcinomas:correlation with clinicopathologic characteristics and Helicobacter pylori infection[J].Oncology,2001,60(4):339-345. 17Terres AM,Pajares JM,O'Toole D,et al.Hp infection is associated with downreg-ulation of E-cadherin,a molecule involved in epithelial cell adhesion and prolifer-ation control[J].Journal of Clinical Pathology,1998,51(5):410-412.

[1]	付依凡, 王博达, 何阳菘, 卢瑗瑗, 王新. 胃癌液体活检中肿瘤生物标志物研究进展[J]. 中国癌症防治杂志, 2024, 16(6): 673-680.
[2]	郭芝妤, 曹田宇, 王伟东, 郭星娴, 马婉琪, 卢瑗瑗, 赵晓迪, 季刚. 胃癌手术患者血脂水平与生存预后的相关性：一项回顾性队列研究[J]. 中国癌症防治杂志, 2024, 16(6): 687-693.
[3]	董军令, 杨惠, 李娜. 1992—2021年中国居民胃癌发病率变化趋势分析[J]. 中国癌症防治杂志, 2024, 16(5): 593-597.
[4]	颜海清, 赖沁巧, 吴留成, 王婷安, 夏想, 黄名威, 覃宇周. SH3BGRL对胃癌细胞增殖、迁移的影响[J]. 中国癌症防治杂志, 2024, 16(3): 285-294.
[5]	覃黎明, 周子寒, 曹骥, 李秋林, 余家华, 容敏华, 赵利彬, 麦月姣, 葛莲英, 覃宇周, 余红平. 2011—2018年广西胃癌流行特征及疾病负担分析[J]. 中国癌症防治杂志, 2024, 16(2): 172-178.
[6]	牛省利, 刘博伟. 高钠饮食对我国居民1990—2019年胃癌疾病负担的影响及趋势分析[J]. 中国癌症防治杂志, 2024, 16(2): 186-192.
[7]	马福超, 刘爱群, 谢为舜, 沈妍华, 冯洁, 蒋旗, 葛莲英. 胃癌发生过程中风险miRNAs筛选及其诊断效能评价的多中心研究[J]. 中国癌症防治杂志, 2024, 16(2): 193-199.
[8]	朱云芳, 许雯, 肖义泽, 文洪梅, 陈杨, 石青萍, 任思颖, 成会荣, 朱林芳. 2016年云南省肿瘤登记地区胃癌发病和死亡情况及2012—2016年变化趋势[J]. 中国癌症防治杂志, 2022, 14(5): 515-520.
[9]	陈明干, 龚庆豪, 戴刚, 张美峰, 张捷. 术前白蛋白与碱性磷酸酶比值在胃癌根治术后患者预后中的预测价值 [J]. 中国癌症防治杂志, 2022, 14(4): 407-411.
[10]	蒋健, 左云, 倪晨, 朱惠平. 阿帕替尼对胃癌HGC-27细胞放射敏感性的影响及其作用机制[J]. 中国癌症防治杂志, 2022, 14(2): 154-159.
[11]	李戴牟, 吴留成, 梁榜辉, 潘佳宇, 王婷安, 韦尉元, 金钦文, 凌通, 黄名威, 覃宇周. 基于转录组测序分析弥漫型胃癌特征及其核心基因LUM的表达 [J]. 中国癌症防治杂志, 2022, 14(2): 160-166.
[12]	周高云, 林龙, 林进维, 苏德文. MLH1表达对胃癌患者预后及术前新辅助化疗反应的预测价值[J]. 中国癌症防治杂志, 2022, 14(1): 65-69.
[13]	蔡心连, 黄月丽, 钟毅, 刘爱群. 2019年度广西上消化道癌机会性筛查结果分析[J]. 中国癌症防治杂志, 2021, 13(6): 662-666.
[14]	吴留成, 陈建思, 覃宇周, 黄名威, 金钦文. 进展期胃癌新辅助治疗病理完全缓解的研究进展[J]. 中国癌症防治杂志, 2021, 13(5): 559-564.
[15]	贾葵, 陈俊强, 唐梦娟. 胃癌患者肌肉减少症的研究进展[J]. 中国癌症防治杂志, 2021, 13(4): 441-446.